Triazolopyrazine derivatives
US7732604B2 · kind B2 · utility
5Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2007 |
| Grant date | Jun 8, 2010 |
| Priority date | — |
| Expiry date | Oct 18, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of the formula Ior a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.